Hostname: page-component-74656f9884-rdgjk Total loading time: 0 Render date: 2026-11-08T01:45:25.050Z Has data issue: false hasContentIssue false
  • English
  • Français

The G allele in IL-10-1082 G/A may have a role in lowering the susceptibility to panic disorder in female patients

Published online by Cambridge University Press:  06 June 2016

Han-Joon Kim  and
Yong-Ku Kim
Han-Joon Kim
Affiliation:
Department of Psychiatry, College of Medicine, Korea University, Seoul, Republic of Korea
Yong-Ku Kim*
Affiliation:
Department of Psychiatry, College of Medicine, Korea University, Seoul, Republic of Korea
*
Prof. Dr. Yong-Ku Kim, Department of Psychiatry, Korea University Ansan Hospital, Korea University College of Medicine, 123 Jeokgeum-ro, Danwon-gu, Ansan 152-703, Republic of Korea. Tel: +82-31-412-5138; Fax: +82-31-412-5132; E-mail: yongku@korea.ac.kr
Rights & Permissions [Opens in a new window]

Abstract

Background

Immune system activation is involved in the pathophysiology of panic disorder (PD). We investigated INF-γ+874 A/T, TNF-α-308 G/A, and IL-10-1082 G/A single nucleotide polymorphisms (SNPs) to determine their association with PD.

Method

This study enroled 135 PD patients and 135 healthy controls. INF-γ+874 A/T (rs2430561), TNF-α-308 G/A (rs1800629), and IL-10-1082 G/A (rs1800896) were genotyped.

Results

There were no differences in genotypes or allele frequencies between the patient and control groups, regardless of accompanying agoraphobia. However, for female patients, the G allele frequency in IL-10 SNP was higher in the control group than in the patient group. Additionally, the female control group had a higher frequency of the A/G and G/G genotype in the IL-10 SNP than the female patient group.

Conclusion

We suggest that the G allele in IL-10-1082 G/A might have a role in reducing the manifestations of PD in female patients. Further studies are needed to extend and confirm our findings.

Keywords

cytokineIFN-rIL-10panic disorderTNF-α

Information

Type
Short Communication
Information
Acta Neuropsychiatrica , Volume 28 , Issue 6 , December 2016 , pp. 357 - 361
Check for updates
Copyright
© Scandinavian College of Neuropsychopharmacology 2016 

Significant outcomes

  • ∙ The G allele in IL-10-1082 G/A might have a role in reducing the manifestations of panic disorder in female patients.

  • ∙ Gender differences in gene polymorphisms can alter the manifestations of panic disorder.

Limitations

  • ∙ Our sample size was relatively small.

  • ∙ Further studies are required to extend and confirm our preliminary findings in a larger sample of participants matched for age and gender.

Introduction

Panic disorder (PD) is classified as an anxiety disorder with repeated and unexpected panic attacks. Although PD is a common mental disorder with great disease burden, only a few convincing risk genes have been reported, with its genetic component proven by family and twin studies (Reference Hettema, Neale and Kendler1,Reference Kessler2).

Previous studies have led to the increasing recognition that pro-inflammatory cytokines could enhance the activity of enzymes related to the degradation of neurotransmitters, suggesting that immune system activation is involved in the pathophysiology of psychiatric disorders, including PD (Reference Myint and Kim3,Reference Myint and Kim4). Additionally, a broad spectrum of cytokine abnormalities, which suggest a generalised inflammatory state, may be present in individuals with PD (Reference Hoge, Brandstetter, Moshier, Pollack, Wong and Simon5). One study suggested that IL-1β levels are a marker of PD (Reference Brambilla, Bellodi, Perna, Bertani, Panerai and Sacerdote6), while another suggested that IL-3 levels were sensitive to the presence of anxiety and stress (Reference Weizman, Laor, Wiener, Wolmer and Bessler7). However, cytokine changes have not been found in experimentally provoked panic attacks (Reference van Duinen, Schruers and Kenis8).

Despite increasing interest in the biological factors underlying PD, few studies have been conducted on the associations between PD and its genetic aetiologies, with the exception of serotonin-related gene polymorphisms (Reference Yoon, Yang, Lee and Kim9–Reference Choi, Lee, Yang and Kim11). Genetic polymorphisms of BDNF and the adenosine receptor have also been studied for their relationship with PD, but no association has been demonstrated (Reference Lam, Cheng, Hong and Tsai12,Reference Lam, Hong and Tsai13). There has not been an association identified between IL-10 genotypes and PD (Reference Koido, Eller and Kingo14).

Given insufficient data on the inflammatory pathophysiology of PD, we tried to detect a possible relationship between cytokine genotypes and allele frequencies in PD patients. We selected IFN-r+874 A/T, TNF-α-308 G/A, and IL-10-1082 G/A single nucleotide polymorphisms (SNPs) due to their functionality in inflammation regulation (Reference Wilson, Symons, McDowell, McDevitt and Duff15–Reference Chong, Ip and Tso19), and hypothesised that these SNPs could be associated with PD.

Furthermore, as female patients have greater susceptibility to PD than male patients (Reference Hoppe, Ipser, Gorman and Stein20), we aimed to detect possible differences between subgroups divided by gender and the presence of accompanying agoraphobia. We believe that the identification of positive associations would aid in the understanding of the pathogenesis of PD.

Methods

Participants and assessments

A total of 135 patients were diagnosed with panic disorder with or without agoraphobia according to DSM-IV diagnostic criteria. Each patient was assessed by clinical interviews using the Structured Clinical Interview for DSM-IV (SCID) (Reference First and Gibbon21), and patients with premorbid schizophrenia, mood disorder, and other anxiety disorders were excluded from the study.

We enroled 135 healthy individuals in the normal control group who visited the Hospital for regular health screenings. Patients were randomly selected and excluded if they had any cancer, hypertension, diabetes mellitus, hepatitis, dyslipidemia, psychiatric family history, or a history of using psychotropic drugs. All patients enroled in the study were biologically unrelated native Koreans. The study protocol was approved by the Ethics Committee of Korea University, and written informed consent was obtained from all participants.

DNA analysis

INF-γ+874 A/T (rs2430561), TNF-α-308 G/A (rs1800629), and IL-10-1082 G/A (rs1800896) were genotyped. The genotyping of the SNPs was conducted based on methods reported in previous studies (Reference Vinasco, Beraun and Nieto22–Reference Bai, Lin and Zeng24).

Statistical analysis

Demographic and clinical variables between the patient group and control group were analysed using the χ2 test, Fisher’s exact test, and independent t-test. Deviations from a theoretical distribution of genotypes were analysed using Hardy–Weinberg equilibrium, which was tested using the χ2 test for goodness of fit. Statistical analysis was performed using SPSS version 12.0 for Windows. The significance level was set at p<0.05 for all statistical analyses.

Results

The gender distribution between the PD patients and healthy controls was M : F=71 : 64 and M : F=54 : 81, respectively, and the mean ages of each group were 38.56±8.58 and 37.02±6.97 years, respectively. There were no significant differences in the gender distribution (χ2=4.31, p=0.051) and mean age (t=1.619, p=0.107) between the two groups.

The distributions of the three polymorphisms in PD patients and controls were in agreement with Hardy–Weinberg equilibrium. The Hardy–Weinberg equilibria of the three genes were as follows: INF-γ+874 A/T (rs2430561) (PD, χ2=1.285, df=1, p=0.257; controls, χ2=0.077, df=1, p=0.781); TNF-α-308 G/A (rs1800629) (PD, χ2=0.645, df=1, p=0.422; controls, χ2=0.789, df=1, p=0.374); and IL-10-1082 G/A (rs1800896) (PD, χ2=1.394, df=1, p=0.2377; controls, χ2=0.004, df=1, p=0.953).

Comparisons between the PD and control groups in terms of INF-γ and TNF-α polymorphisms are summarised in Tables 1 and 2. There were no significant differences in genotype or allele frequency between the two groups. Male and female subgroups revealed no significant differences with either genotype. Other subgroups, regardless of the presence of agoraphobia, were compared, but no statistically significant differences were observed.

Table 1

Genotype and allele frequencies of IFNr874A/T in panic disorder (PD) patients and controls

Table 2

Genotype and allele frequencies of TNF-α G/A in panic disorder (PD) patients and controls

There was also no significant difference between the patient and control groups in terms of the genotype or allele frequency of the IL-10 gene (Table 3). In the female subgroup, the G allele frequency was higher in the control group than in the PD group (χ2=6.51, p=0.01), and the proportions of A/G and G/G were higher in the female control group than in the female PD patients (χ2=6.42, p=0.04).

Table 3

Genotype and allele frequencies of IL10A/G in panic disorder (PD) patients and controls

The age of onset of panic disorder was 33.0±10.2 years, and the duration of panic disorder was 22.0±9.3 months. There was no significant association between these polymorphisms and the age of onset or duration of illness in patients with panic disorder.

Discussions

To evaluate the pathophysiology of PD, we studied polymorphisms of INF-γ+874 A/T, TNF-α-308 G/A, and IL-10-1082 G/A based on molecular evidence for their functionality in inflammation (Reference Paul-Samojedny, Kowalczyk and Suchanek25).

These three SNPs were previously studied in patients with suicidal attempts, and the INF-γ+874 A/A, TNF-α-308 G/G, and IL-10-1082 A/A genotypes were demonstrated to show an association with suicide attempts (Reference Omrani, Bushehri and Bagheri26). Another study investigated the association between these SNPs with suicide attempts in patients with major depressive disorder (MDD), which showed that the TNF-α-308 G/A polymorphism was an independent risk factor for suicide attempts in patients with MDD (Reference Kim, Hong and Hwang27).

In comparison to previous reports, this study did not find significant differences in the genotype and allele frequencies of these 3 SNPs between the PD groups and the control groups; however, the G allele frequency in IL-10 was higher in the female control group than in female PD patients.

Some studies have reported that gender-specific gene promoter polymorphisms of the serotonin transporter disturb the HPA axis by controlling cortisol secretion (Reference Wust, Kumsta and Treutlein28), which is reflected in the manifestation of PD (Reference Dell’Osso, Marazziti and Da Pozzo29). These gender differences in gene polymorphisms, which can alter the manifestations of PD, were the reason we subdivided our study groups by gender. Although these results are limited by the small sample size due to the use of subgroups, which is a common methodological difficulty for such investigations, we suggest that the G allele in IL-10-1082 G/A might have a role in reducing the manifestations of PD in female patients.

As an anti-inflammatory cytokine, the association between IL-10 and MDD has been previously studied (Reference Traks, Koido and Eller30). IL-10 inhibits the nearly ubiquitous expression of indoleamine 2,3-deoxygenase (IDO), an enzyme responsible for directing tryptophan degradation, which is directly related to the ‘neurodegeneration hypothesis’ of psychiatric disorders (Reference Myint and Kim4,Reference Weiss, Murr and Zoller31). However, only a few studies have been performed investigating the relationship between IL-10 and PD. One study showed no significant association between SNPs in the IL-10 family of genes and PD patients (Reference Koido, Eller and Kingo14). This study examined the rs1554286, rs2243176, rs1890866 SNPs of IL-10, which did not include our IL-10 SNP has limitation for including MDD.

Stress results in lipopolysaccharide (LPS) – induced IL-10 production, and IL-10 is known to inhibit the production of INF-γ and TNF-α (Reference Tukel, Arslan and Ertekin32). Although the normalisation of IL-10 does not reverse the inhibition of cytokine regulation, we assumed that the negative results for INF-γ and TNF-α in our study could be due to the secondary effects of IL-10.

We suggest that our observed genotype and allele frequencies should be taken in context of our relatively small sample sizes. Further studies are required to extend and confirm our preliminary findings in a large sample of participants matched for age and gender.

Acknowledgement

Authors’ Contributions: Han-Joon Kim and Yong-Ku Kim designed the study and wrote the protocol. Han-Joon Kim wrote the first draft of the manuscript. All authors contributed to and have approved the final manuscript. This paper was carried out as the Master’s thesis of Han-Joon Kim. We thank Jung-A Hwang for the laboratory work.

Financial Support

This paper was supported by Korea University.

Conflicts of Interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Ethical Standards

All authors assert that all procedures contributing to this work complied with ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.

References

1. Hettema, JM, Neale, MC, Kendler, KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001;158:1568–1578.Google Scholar
2. Kessler, R. Review: major anxiety disorders all have substantive familial aggregation. Evid Based Ment Health 2002;5:92.CrossRefGoogle ScholarPubMed
3. Myint, AM, Kim, YK. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 2003;61:519–525.Google Scholar
4. Myint, AM, Kim, YK. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 2014;48:304–313.Google Scholar
5. Hoge, EA, Brandstetter, K, Moshier, S, Pollack, MH, Wong, KK, Simon, NM. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety 2009;26:447–455.Google Scholar
6. Brambilla, F, Bellodi, L, Perna, G, Bertani, A, Panerai, A, Sacerdote, P. Plasma interleukin-1 beta concentrations in panic disorder. Psychiatry Res 1994;54:135–142.CrossRefGoogle ScholarPubMed
7. Weizman, R, Laor, N, Wiener, Z, Wolmer, L, Bessler, H. Cytokine production in panic disorder patients. Clinical neuropharmacology 1999;22:107–109.CrossRefGoogle ScholarPubMed
8. van Duinen, MA, Schruers, KR, Kenis, GR et al. Effects of experimental panic on neuroimmunological functioning. J Psychosom Res 2008;64:305–310.CrossRefGoogle ScholarPubMed
9. Yoon, HK, Yang, JC, Lee, HJ, Kim, YK. The association between serotonin-related gene polymorphisms and panic disorder. J Anxiety Disord 2008;22:1529–1534.CrossRefGoogle ScholarPubMed
10. Kim, YK, Lee, HJ, Yang, JC, Hwang, JA, Yoon, HK. A tryptophan hydroxylase 2 gene polymorphism is associated with panic disorder. Behav Genet 2009;39:170–175.Google Scholar
11. Choi, WS, Lee, BH, Yang, JC, Kim, YK. Association study between 5-HT1A receptor gene C(-1019)G polymorphism and panic disorder in a Korean population. Psychiatry Investig 2010;7:141–146.CrossRefGoogle Scholar
12. Lam, P, Cheng, CY, Hong, CJ, Tsai, SJ. Association study of a brain-derived neurotrophic factor (Val66Met) genetic polymorphism and panic disorder. Neuropsychobiology 2004;49:178–181.CrossRefGoogle ScholarPubMed
13. Lam, P, Hong, CJ, Tsai, SJ. Association study of A2a adenosine receptor genetic polymorphism in panic disorder. Neurosci Lett 2005;378:98–101.CrossRefGoogle ScholarPubMed
14. Koido, K, Eller, T, Kingo, K et al. Interleukin 10 family gene polymorphisms are not associated with major depressive disorder and panic disorder phenotypes. J Psychiatr Res 2010;44:275–277.Google Scholar
15. Wilson, AG, Symons, JA, McDowell, TL, McDevitt, HO, Duff, GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195–3199.Google Scholar
16. Crawley, E, Kay, R, Sillibourne, J, Patel, P, Hutchinson, I, Woo, P. Polymorphic haplotypes of the interleukin-10 5’ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999;42:1101–1108.3.0.CO;2-Y>CrossRefGoogle ScholarPubMed
17. Pravica, V, Perrey, C, Stevens, A, Lee, JH, Hutchinson, IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000;61:863–866.Google Scholar
18. Tso, HW, Ip, WK, Chong, WP, Tam, CM, Chiang, AK, Lau, YL. Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun 2005;6:358–363.Google Scholar
19. Chong, WP, Ip, WK, Tso, GH et al. The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome. BMC Infect Dis 2006;6:82.Google Scholar
20. Hoppe, LJ, Ipser, J, Gorman, JM, Stein, DJ. Panic disorder. Handb Clin Neurol 2012;106:363–374.Google Scholar
21. First, M SR, Gibbon, M. Structured Clinical Interview for DSM-IV Axis I Disorder, patient edition. New York State Psychiatric Institute, New York, 1998.Google Scholar
22. Vinasco, J, Beraun, Y, Nieto, A et al. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 1997;49:74–78.Google Scholar
23. Edwards-Smith, CJ, Jonsson, JR, Purdie, DM, Bansal, A, Shorthouse, C, Powell, EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 1999;30:526–530.Google Scholar
24. Bai, J, Lin, M, Zeng, X et al. Association of polymorphisms in the human IFN-gamma and IL-4 gene with oral lichen planus: a study in an ethnic Chinese cohort. J Interferon Cytokine Res 2008;28:351–358.Google Scholar
25. Paul-Samojedny, M, Kowalczyk, M, Suchanek, R et al. Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia--a case-control study. J Mol Neurosci 2010;42:112–119.Google Scholar
26. Omrani, MD, Bushehri, B, Bagheri, M et al. Role of IL-10-1082, IFN-gamma +874, and TNF-alpha -308 genes polymorphisms in suicidal behavior. Arch Suicide Res 2009;13:330–339.Google Scholar
27. Kim, YK, Hong, JP, Hwang, JA et al. TNF-alpha -308G>A polymorphism is associated with suicide attempts in major depressive disorder. J Affect Disord 2013;150:668–672.Google Scholar
28. Wust, S, Kumsta, R, Treutlein, J et al. Sex-specific association between the 5-HTT gene-linked polymorphic region and basal cortisol secretion. Psychoneuroendocrinology 2009;34:972–982.Google Scholar
29. Dell’Osso, L, Marazziti, D, Da Pozzo, E et al. Gender effect on the relationship between stress hormones and panic-agoraphobic spectrum dimensions in healthy subjects. CNS Spectrums 2012;17:214–220.CrossRefGoogle ScholarPubMed
30. Traks, T, Koido, K, Eller, T et al. Polymorphisms in the interleukin-10 gene cluster are possibly involved in the increased risk for major depressive disorder. BMC Med Genet 2008;9:111.CrossRefGoogle ScholarPubMed
31. Weiss, G, Murr, C, Zoller, H et al. Modulation of neopterin formation and tryptophan degradation by Th1-and Th2-derived cytokines in human monocytic cells. Clin Exp Immunol 1999;116:435–440.Google Scholar
32. Tukel, R, Arslan, BA, Ertekin, BA et al. Decreased IFN-gamma and IL-12 levels in panic disorder. J Psychosom Res 2012;73:63–67.Google Scholar
Figure 0

Table 1 Genotype and allele frequencies of IFNr874A/T in panic disorder (PD) patients and controls

Figure 1

Table 2 Genotype and allele frequencies of TNF-α G/A in panic disorder (PD) patients and controls

Figure 2

Table 3 Genotype and allele frequencies of IL10A/G in panic disorder (PD) patients and controls